Research.Patient.info
Nonsquamous Non-small Cell Lung Cancer research hub
2 indexed studies · 0 currently recruiting
- active not recruitingPHASE3
HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy
This study looks at a new drug, patritumab deruxtecan, for a type of lung cancer that has stopped responding to standard treatments. It compares this new drug with traditional chemotherapy to see if it works better and is safer for patients.
United States · Australia · Austria - ongoing, recruitingTherapeutic exploratory (Phase II)
A randomized, double-blind, placebo-controlled, Phase 2 study evaluating efficacy and safety of inupadenant in combination with carboplatin and pemetrexed in adults with nonsquamous non-small cell lung cancer who have progressed on immunotherapy
This study is testing a new medicine, inupadenant, combined with standard chemotherapy for adults in the UK with a type of lung cancer (nonsquamous non-small cell lung cancer) that has worsened after immunotherapy. Researchers want to see if this new combination helps patients live longer without their cancer growing.
Spain · Czechia · France